0001213900-24-022663.txt : 20240314
0001213900-24-022663.hdr.sgml : 20240314
20240314171210
ACCESSION NUMBER: 0001213900-24-022663
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240314
DATE AS OF CHANGE: 20240314
EFFECTIVENESS DATE: 20240314
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADIAL PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001513525
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 800667150
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-507664
FILM NUMBER: 24751238
BUSINESS ADDRESS:
STREET 1: 1180 SEMINOLE TRAIL
STREET 2: SUITE 495
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22901
BUSINESS PHONE: 434-422-9800
MAIL ADDRESS:
STREET 1: 1180 SEMINOLE TRAIL
STREET 2: SUITE 495
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22901
FORMER COMPANY:
FORMER CONFORMED NAME: ADial Pharmaceuticals, L.L.C.
DATE OF NAME CHANGE: 20170515
FORMER COMPANY:
FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C.
DATE OF NAME CHANGE: 20110218
D
1
primary_doc.xml
X0708
D
LIVE
0001513525
ADIAL PHARMACEUTICALS, INC.
4870 SADLER ROAD, SUITE 300
GLEN ALLEN
VA
VIRGINIA
23060
(804) 487-8196
DELAWARE
Adial Pharmaceuticals L.L.C.
ADial Pharmaceuticals, L.L.C.
Adial Pharmaceuticals, L.L.C.
Corporation
true
Cary
J.
Claiborne
4870 Sadler Road, Suite 300
Glen Allen
VA
VIRGINIA
23060
Executive Officer
Director
Joseph
M.
Truluck
4870 Sadler Road, Suite 300
Glen Allen
VA
VIRGINIA
23060
Executive Officer
James
K.
Anderson
4870 Sadler Road, Suite 300
Glen Allen
VA
VIRGINIA
23060
Director
Robertson
H.
Gilliland
4870 Sadler Road, Suite 300
Glen Allen
VA
VIRGINIA
23060
Director
Bankole
A.
Johnson
4870 Sadler Road, Suite 300
Glen Allen
VA
VIRGINIA
23060
Executive Officer
James
W.
Newman, Jr.
4870 Sadler Road, Suite 300
Glen Allen
VA
VIRGINIA
23060
Director
Kevin
Schuyler, CFA
4870 Sadler Road, Suite 300
Glen Allen
VA
VIRGINIA
23060
Director
Tony
Goodman
4870 Sadler Road, Suite 300
Glen Allen
VA
VIRGINIA
23060
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2024-03-06
false
true
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 PARK AVENUE
NEW YORK
NY
NEW YORK
10022
NY
NEW YORK
false
287500
287500
0
Includes an aggregate exercise price of warrants of $0.125
true
0
1
23000
true
0
Includes cash fee equal to 7% & a 1% management fee of the aggregate gross proceeds of the private placement The issuer issued to placement agent (and warrants to purchase up to 85,106 shares at an exercise price of $3.25).
0
true
While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers
false
ADIAL PHARMACEUTICALS, INC.
/s/ Cary J. Claiborne
Cary J. Claiborne
Chief Executive Officer
2024-03-14